Free Trial
NYSEAMERICAN:VTAK

Catheter Precision (VTAK) Stock Price, News & Analysis

Catheter Precision logo
$0.22 0.00 (-0.58%)
Closing price 04:10 PM Eastern
Extended Trading
$0.22 0.00 (-0.31%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Catheter Precision Stock (NYSEAMERICAN:VTAK)

Key Stats

Today's Range
$0.22
$0.24
50-Day Range
$0.19
$0.60
52-Week Range
$0.16
$3.05
Volume
863,614 shs
Average Volume
4.54 million shs
Market Capitalization
$2.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catheter Precision Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

VTAK MarketRank™: 

Catheter Precision scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Catheter Precision.

  • Earnings Growth

    Earnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.

  • Price to Book Value per Share Ratio

    Catheter Precision has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Catheter Precision's valuation and earnings.
  • Percentage of Shares Shorted

    54.62% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 79.14%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Catheter Precision does not currently pay a dividend.

  • Dividend Growth

    Catheter Precision does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    54.62% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 79.14%, indicating that investor sentiment is decreasing significantly.
  • MarketBeat Follows

    1 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Catheter Precision insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.95% of the stock of Catheter Precision is held by insiders.

  • Percentage Held by Institutions

    Only 20.34% of the stock of Catheter Precision is held by institutions.

  • Read more about Catheter Precision's insider trading history.
Receive VTAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter.

VTAK Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

VTAK Stock Analysis - Frequently Asked Questions

Catheter Precision's stock was trading at $0.4491 on January 1st, 2025. Since then, VTAK shares have decreased by 50.2% and is now trading at $0.2237.

Catheter Precision's stock reverse split on the morning of Monday, July 15th 2024.The 1-10 reverse split was announced on Monday, July 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB).

Company Calendar

Today
7/17/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:VTAK
CIK
1716621
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.64 million
Net Margins
-3,744.91%
Pretax Margin
-3,242.41%
Return on Equity
-153.90%
Return on Assets
-68.25%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.21
Quick Ratio
0.19

Sales & Book Value

Annual Sales
$420 thousand
Price / Sales
5.87
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
0.17

Miscellaneous

Outstanding Shares
11,020,000
Free Float
10,692,000
Market Cap
$2.47 million
Optionable
N/A
Beta
-0.72
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSEAMERICAN:VTAK) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners